BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19542712)

  • 1. [Treatment of cancer of unknown primary, today and future].
    Shibata H
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):918-22. PubMed ID: 19542712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
    Kato S; Yasuda K; Nishino Y; Ohori H; Takahashi M; Takahashi S; Yamaura G; Ohtsuka K; Kakudo Y; Chiba N; Shimodaira H; Sakayori M; Kato S; Suzuki T; Murakawa Y; Gamoh M; Shibata H; Yoshioka T; Ishioka C
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1227-31. PubMed ID: 17687203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraclavicular lymph node metastases of unknown origin: HPV-typing identifies the primary tumour.
    Kuemper C; Burges A; Hillemanns P; Mueller-Egloff S; Lenhard M; Ditsch N; Strauss A
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):606-11. PubMed ID: 19549285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
    Pentheroudakis G; Golfinopoulos V; Pavlidis N
    Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unknown primary tumour--diagnostic strategies and treatment].
    Møller AK; Gundgaard MG; Petersen BL; Daugaard G
    Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unknown primary cancer].
    Furue H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of unknown primary site-current status and future direction].
    Ichikawa Y; Okamoto I; Nakagawa K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):907-9. PubMed ID: 19542709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic carcinoma of unknown origin].
    Fizazi K; Culine S
    Bull Cancer; 1998 Jul; 85(7):609-17. PubMed ID: 9752267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study.
    Sève P; Mackey J; Sawyer M; Lesimple T; de La Fouchardière C; Broussolle C; Dumontet C; Ray-Coquard I
    Bull Cancer; 2009 Apr; 96(4):E7-17. PubMed ID: 19435692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Limit investigation in cancer of unknown primary site].
    Berglund A; Nygren P; Hagberg H; Påhlman L; Sundin A; Sundström C
    Lakartidningen; 2005 Oct 10-16; 102(41):2946-8, 2950-2. PubMed ID: 16294513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer of unknown primary site: missing primary or missing biology?
    Pentheroudakis G; Briasoulis E; Pavlidis N
    Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CUP syndrome: are there advances?].
    Moll R
    Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis.
    Golfinopoulos V; Pentheroudakis G; Salanti G; Nearchou AD; Ioannidis JP; Pavlidis N
    Cancer Treat Rev; 2009 Nov; 35(7):570-3. PubMed ID: 19539430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.
    Amela EY; Lauridant-Philippin G; Cousin S; Ryckewaert T; Adenis A; Penel N
    Crit Rev Oncol Hematol; 2012 Nov; 84(2):213-23. PubMed ID: 22503530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of unknown primary origin: a decade of experience in a community-based hospital.
    Pimiento JM; Teso D; Malkan A; Dudrick SJ; Palesty JA
    Am J Surg; 2007 Dec; 194(6):833-7; discussion 837-8. PubMed ID: 18005780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
    Horlings HM; van Laar RK; Kerst JM; Helgason HH; Wesseling J; van der Hoeven JJ; Warmoes MO; Floore A; Witteveen A; Lahti-Domenici J; Glas AM; Van't Veer LJ; de Jong D
    J Clin Oncol; 2008 Sep; 26(27):4435-41. PubMed ID: 18802156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2005 Jun; 54(3):243-50. PubMed ID: 15890271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of unknown primary site.
    Schlag PM; Hünerbein M
    Ann Chir Gynaecol; 1994; 83(1):8-12. PubMed ID: 8053645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.